Workflow
纳米炭铁混悬注射液
icon
Search documents
莱美药业(300006) - 2025年投资者网上集体接待日暨半年度业绩说明会投关记录表
2025-09-25 11:42
| 投资者关系活动类 | □特定对象调研 □分析师会议 | | --- | --- | | 别 | □媒体采访 √业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 (请文字说明其他活动内容) | | 参与单位名称及人 | 线上参与莱美药业参加的"重庆辖区举办的 2025 年投 | | 员姓名 | 资者网上集体接待日暨半年度业绩说明会活动"的投资 | | | 者 | | 时间 | 2025 年 9 月 25 日(星期四)下午 15:00-17:00 | | 地点 | 全景网"投资者关系互动平台" | | 上市公司接待人员 | 财务总监:赖文女士 | | 姓名 | 董事会秘书、副总经理:崔丹先生 | | | 公司于 2025 年 9 月 25 日(星期四)15:00-17:00 在 | | | 全景网"投资者关系互动平台"(https://ir.p5w.net) | | | 采用网络远程的方式召开"2025 年投资者网上集体接待 | | | 日暨半年度业绩说明会"。业绩说明会问答环节主要内 | | | 容如下: | | | 1、中恒集团何时转让莱美药业股权,去年暂缓转让 ...
中恒集团:以可持续发展为轴 卷动社会价值共创新生态
Core Insights - Zhongheng Group has released its 15th Social Responsibility Report, highlighting its practices in rural revitalization, green low-carbon transformation, and ensuring public welfare, receiving multiple honors including recognition in the ESG Pioneer 100 Index and as an excellent practice case for sustainable development in 2024 [1] Group 1: Green Development and Low-Carbon Transformation - The company is committed to green development, aligning with the national "dual carbon" goals, and has invested in energy conservation, emission reduction, clean production, and renewable energy utilization [1] - Zhongheng promotes green pest control and wild-simulated planting techniques, and is establishing a rescue base for the national second-level protected plant, promoting a green ecological circle for traditional Chinese medicine [1] - The company extends its environmental protection philosophy through activities like World Environment Day and tree planting [1] Group 2: Social Responsibility and Health Care - Zhongheng actively responds to national policies, with multiple products renewing contracts or winning bids in national and provincial centralized procurement, enhancing the accessibility of clinical medications and reducing patient burdens [1] - The company explores a "industry + technology + public welfare" model for rural revitalization, supporting the construction of traditional Chinese medicine material bases to increase farmers' income [1] - Zhongheng integrates intangible cultural heritage techniques with modern production technology to develop new products like sugar-free Liubao tea and black bean milk [1] - The company engages in volunteer services such as the Zhongheng Scholarship, Mother's Smile Initiative, and the Elderly and Children Care Project, continuously delivering warmth to society [1] Group 3: Corporate Governance and Development - Zhongheng focuses on modernizing its governance system, continuously improving its governance structure and establishing a long-term shareholder return mechanism [2] - Since its listing, the company has distributed a total of 2.941 billion yuan in dividends and repurchased nearly 173 million shares, demonstrating confidence in its corporate value [2] - In 2024, Zhongheng plans to establish three new provincial-level research platforms and has been approved for two Guangxi Natural Science Fund projects [2] - The company is advancing the development of innovative traditional Chinese medicine products and has received approvals for multiple drug varieties, solidifying its position in the industry [2] - Zhongheng aims to maintain a pragmatic approach, collaborating with partners to contribute to comprehensive reform and the modernization of China [2]